Dr Charlott Repschlager is a Volunteer Writer at BioNews and works at the German Federal Institute for Risk Assessment in Berlin. She has completed a PhD at King's College London Institute of Psychiatry, Psychology & Neuroscience. Previously, she has worked as a postdoctoral researcher in cancer at Queen Mary University of London and as a science communications officer. She has studied Human and Medical Science at the University of Westminster.
Blood samples have been collected from newborns as Genomics England embarks on its Generation Study...
A genetic mutation known to increase the risk of various cancers, including breast and ovarian cancers, has been linked to infertility in mice...
The downregulation of a normally protective gene drives pancreatic cancer growth and aggressiveness...
How an individual's genetics influences their immune systems' response to sepsis has been investigated by a team of UK researchers...
Mutations in the human genome occur more often than previously expected, but are not deemed harmful, according to a new study...
A genetic link between the characteristics of growth spurts during puberty and health conditions, such as atrial fibrillation, later in life has been uncovered...
New genetic markers that drive the development of type 2 diabetes and other vascular diseases have been identified...
Researchers have found that counselling before or after taking a genetic test to assess the risk of developing ovarian or breast cancer does not reduce distress, anxiety or depression...
Depression may directly cause an increased risk of developing type 2 diabetes, with scientists identifying seven genetic variants that are involved in both diseases...
Researchers have identified four new breast-cancer-associated genes that have the potential to help improve clinical screening for women at risk...
Join our list to stay up-to-date on all the latest developments in the fields of human fertility and genomics.
